[Chinese guideline for the diagnosis and treatment of Takayasu's arteritis(2023)].

Authors:
  • NHNational Clinical Research Center for Dermatologic and Immunologic Diseases(Peking Union Medical College Hospital)
    National Clinical Research Center for Dermatologic and Immunologic Diseases(Peking Union Medical College Hospital)
  • VPVasculitis Study Group of Chinese Association of Rheumatology and Immunology Physicians
    Vasculitis Study Group of Chinese Association of Rheumatology and Immunology Physicians
  • VAVasculitis Study Group of Special Committee on Rheumatology and Immunology of Cross⁃Straits Medicine Exchange Association
    Vasculitis Study Group of Special Committee on Rheumatology and Immunology of Cross⁃Straits Medicine Exchange Association
  • PAProfessional Committee of Rheumatology and Immunology of the Chinese Rehabilitation Medical Association
    Professional Committee of Rheumatology and Immunology of the Chinese Rehabilitation Medical Association
Google Scholar
  • 1 February 2024
    • journal article
    • abstracts
Abstract
Takayasu's arteritis (TAK) is a chronic granulomatous inflammatory disease that involves the aorta and its primary branch arteries. It is characterized by wall thickening,stenosis or aneurysm formation of involved arteries,leading to ischemia of related organs. The clinical diagnosis and treatment of TAK is challenging. In order to further improve the level of diagnosis and treatment of TAK in China and standardize the diagnosis and treatment of TAK, a clinical practice guidelines based on evidence-based medicine evidence was developed under the leadership of the National Clinical Medical Research Center for Dermatologic and Immunologic Diseases. Eleven recommendations for 11 clinical questions problems that are important to the diagnosis and treatment of TAK were developed based on the latest research evidence and expert opinions, combined with real clinical practice in China.